AVEO Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch AVEO and buy or sell other stocks, ETFs, and their options commission-free!

About AVEO

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353.

CEO

Michael P. Bailey

CEOMichael P. Bailey

Employees

Employees17

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2001

Founded2001

Employees

Employees17

AVEO Key Statistics

Market cap

2.41B

Market cap2.41B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.85M

Average volume1.85M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.85

52 Week high$1.85

52 Week low

$0.4653

52 Week low$0.4653

People also own

Based on the portfolios of people who own AVEO. This list is generated using Robinhood data, and it’s not a recommendation.